Search Results | American Association for Cancer Research

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Abstract 4660: A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small cell lung cancer.

Alberto Chiappori, Tatjana Kolevska, Bart Burington, David Spigel, Steven Hager, Mark Rarick, Shirish Gadgeel, Normand Blais, Joachim Von Pawel, Lowell Hart, Martin Reck, Joan Schiller

Cancer Res (2013) 73 (8_Supplement): 4660.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4660

Published: 15 April 2013

View article

Journal Articles

Abstract 4659: Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

Keon UK Keon Uk, Jin Young Kim, Young Rok Do, Hong Suk Song, Young June Jeon, Hun Mo Ryoo, Sung Hwa Bae, Jong Gwang Kim, Jin Ho Baek, Yee Soo Chae, Min Kyoung Kim, Kyung Hee Lee, Yoon Young Cho

Cancer Res (2013) 73 (8_Supplement): 4659.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4659

Published: 15 April 2013

View article

Journal Articles

Abstract 4658: First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.

Thomas Felzmann, Johanna Buchroithner, Christine Marosi, Martha Nowosielsky, Stefan Oberndorfer, Reinhard Ruckser, Karl Rössler, Amedeo Azizi, Gord von Campe, Karin Bordihn, The Austrian GBM-Vax Consortium

Cancer Res (2013) 73 (8_Supplement): 4658.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4658

Published: 15 April 2013

View article

Journal Articles

Abstract 4669: Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC): the immune and IGFR pathways.

Frederique Penault-llorca, Catherine Abrial, Marie-Melanie Dauplat, Maud Privat, Nancy Uhrhammer, Alexis Desrichard, Yannick Bidet, Nina Radosevic-Robin, Anne Cayre, Cecile Aube, Fabrice Kwiatkowski, Nassera Chalabi, Yves-Jean Bignon, Philippe Chollet, Jean-Marc Nabholtz

Cancer Res (2013) 73 (8_Supplement): 4669.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4669

Published: 15 April 2013

View article

Journal Articles

Abstract 4666: A phase 2 study investigating the safety, efficacy and surrogate biomarkers of response of 5-azacitidine (5-AZA) andentinostat (MS-275) in patients with triple-negative advanced breast cancer.

Roisin M. Connolly, Rachel C. Jankowitz, Cynthia A. Zahnow, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon Slater, Penny Powers, Antonio C. Wolff, John Fetting, Adam M. Brufsky, Richard Piekarz, Nita Ahuja, George Somlo, Augustin Garcia, Steven Baylin, Nancy E. Davidson, Vered Stearns

Cancer Res (2013) 73 (8_Supplement): 4666.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4666

Published: 15 April 2013

View article

Journal Articles

Abstract 4665: VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients.

Herman A. Perroud, Carlos M. Alasino, Maria J. Rico, Francisco Queralt, Stella M. Pezzotto, Viviana R. Rozados, O.Graciela Scharovsky

Cancer Res (2013) 73 (8_Supplement): 4665.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4665

Published: 15 April 2013

View article

Journal Articles

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

Cancer Res (2013) 73 (8_Supplement): 4664.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4664

Published: 15 April 2013

View article

Journal Articles

Abstract 4663: Acquired resistance to gefitinib is associated with cancer stem-like phenotype and EMT in EGFR mutant lung adenocarcinoma.

Sun Min Lim, Hyun Jung Kim, Young Ho Ban, Sang Jun Ha, Byoung Chul Cho

Cancer Res (2013) 73 (8_Supplement): 4663.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4663

Published: 15 April 2013

View article

Journal Articles

Abstract 4668: Antitumor efficacy of AZD1480 in head and neck squamous cell carcinoma.

Malabika Sen, John Black, Sarah Wheeler, Maria L. Freilino, Sonali Joyce, Vivian Lui, Yan Zeng, Korey Marshall, Jennifer R. Grandis

Cancer Res (2013) 73 (8_Supplement): 4668.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4668

Published: 15 April 2013

View article

Journal Articles

Abstract 4667: Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.

Zheng Wu, Narayan Shivapurkar, John L. Marshall, Jimmy Hwang, Michael J. Pishvaian, Tingting Zhuang, Anton Wellstein, Louis M. Weiner, Lisa Ley, Aiwu R. He

Cancer Res (2013) 73 (8_Supplement): 4667.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4667

Published: 15 April 2013

View article

Journal Articles

Abstract 4674: Pilot study of intrahepatic artery chemotherapy in combination with sorafenib in hepatocellular carcinoma patients.

Lynn G. Feun, Govindarajan Narayanan, Jose Yrizarry, Vy Dinh, Niramol Savaraj, Christopher O'Brien, Paul Martin

Cancer Res (2013) 73 (8_Supplement): 4674.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4674

Published: 15 April 2013

View article

Journal Articles

Abstract 4680: Biomarkers of adherence and efficacy: modulation of biomarkers of DNA damage in a Phase 1b trial of post-surgical oral cancer patients on a long-term food-based prevention study with black raspberries.

Lana K. Uhrig, Thomas J. Knobloch, Bruce C. Casto, Amit Agrawal, David E. Schuller, Theodoros N. Teknos, Enver Ozer, Matthew O. Old, Christine L. Sardo, Jeff Xueliang, Steven K. Clinton, Dennis K. Pearl, Christopher M. Weghorst

Cancer Res (2013) 73 (8_Supplement): 4680.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4680

Published: 15 April 2013

View article

Journal Articles

Abstract 4671: Radioguided detection of lymph node metastasis in non-small cell lung cancer.

Chukwumere Nwogu, Todd Demmy, Sai Yendamuri, Wei Tan, Paul Bogner, Elisabeth Dexter, Anthony Picone, Mark Hennon, Alan Hutson, Mary Reid, Richard Cheney, Alex Adjei

Cancer Res (2013) 73 (8_Supplement): 4671.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4671

Published: 15 April 2013

View article

Journal Articles

Abstract 4662: Epigenetic conversion on p53 pathway in human cancer: The clinical potential of p53 mutation status as a predictive biomarker for drug sensitivity by epigenetic treatment.

Keishi Yamashita, Mina Waraya, Hiroshi Katoh, Akira Ooki, Hiroshi Kawamata, Kazunori Nakamura, Hiroshi Nishimiya, Akira Ema, David Sidransky, Masahiko Watanabe

Cancer Res (2013) 73 (8_Supplement): 4662.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4662

Published: 15 April 2013

View article

Journal Articles

Abstract 4681: Characterization of pulmonary hypertension in lung cancer.

Samantha Storn, Soni Savai Pullamsetti, Baktybek Kojonazarov, Ralph Theo Schermuly, Friedrich Grimminger, Ulf R. Rapp, Werner Seeger, Rajkumar Savai

Cancer Res (2013) 73 (8_Supplement): 4681.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4681

Published: 15 April 2013

View article

Journal Articles

Abstract 4661: Clinical study on Compound Zhe Bei Granules (CZBG) combined with chemotherapy to improve the clinical efficacy of refractory acute leukemia.

Xinyi Chen, Li Hou, Shulian Yang, Wenhua Yang, Yuhong Zhou, Feng Liu, Hongyong Yang, Weizheng Sun, Dongyun Li, Yamei Xu

Cancer Res (2013) 73 (8_Supplement): 4661.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4661

Published: 15 April 2013

View article

Journal Articles

Abstract 4673: A randomized, double-blind, multicenter trial evaluating the chronotherapeutic role of concomitant melatonin in the treatment of stage IIIB and IV non-small cell lung carcinoma.

Robert D. Levin, James F. Grutsch, Christopher G. Lis, Digant Gupta, Patricia A. Wood, William JM Hrushesky

Cancer Res (2013) 73 (8_Supplement): 4673.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4673

Published: 15 April 2013

View article

Journal Articles

Abstract 4682: Phase II study of first line chemotherapy with tegafur/uracil and oral leucovorin in elderly patients with advanced or metastatic colorectal cancer.

Kohei Murata, Hirofumi Yamamoto, Mutsumi Fukunaga, Takeshi Kato, Tadashi Ohnishi, Yoshio Uemura, Hirofumi Ohta, Fumihiko Kimura, Masayuki Ohue, Riichiro Nezu, Mitsugu Sekimoto, Masataka Ikeda, Tsunekazu Mizushima, Yuichiro Doki, Masaki Mori, Clinical Study Group of Osaka University (CSGO), Colorectal Group

Cancer Res (2013) 73 (8_Supplement): 4682.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4682

Published: 15 April 2013

View article

Journal Articles

Abstract 4675: Effect and safety of FOLFOXIRI+B-mab as preoperative chemotherapy for multiple liver metastases of colorectal cancer.

Yasushi Ichikawa, Ayumu Goto, Noriotoshi Kobayashi, Motohiko Tokuhisa, Takashi Ishikawa, Kenichi Kondo, Atsushi Ishibe, Kazuteru Watanabe, Mitsuyoshi Ota, Shoichi Fujii, Hirotoshi Akiyama, Kuniya Tanaka, Itaru Endo

Cancer Res (2013) 73 (8_Supplement): 4675.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4675

Published: 15 April 2013

View article

Journal Articles

Abstract 4670: Delayed urticarial reactions in the phase II trial of HER2/neu peptide vaccines + GM-CSF vs. GM-CSF alone in high risk breast cancer patients.

Alfred F. Trappey, John S. Berry, Timothy J. Vreeland, Diane F. Hale, Alan K. Sears, Guy Clifton, Sathibalan Ponniah, Michael Papamichail, Sonia A. Perez, Elizabeth Mittendorf, George E. Peoples

Cancer Res (2013) 73 (8_Supplement): 4670.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4670

Published: 15 April 2013

View article

NARROW

Abstract 4660: A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small cell lung cancer.

Abstract 4659: Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

Abstract 4658: First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.

Abstract 4669: Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC): the immune and IGFR pathways.

Abstract 4666: A phase 2 study investigating the safety, efficacy and surrogate biomarkers of response of 5-azacitidine (5-AZA) andentinostat (MS-275) in patients with triple-negative advanced breast cancer.

Abstract 4665: VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients.

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

Abstract 4663: Acquired resistance to gefitinib is associated with cancer stem-like phenotype and EMT in EGFR mutant lung adenocarcinoma.

Abstract 4668: Antitumor efficacy of AZD1480 in head and neck squamous cell carcinoma.

Abstract 4667: Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.

Abstract 4674: Pilot study of intrahepatic artery chemotherapy in combination with sorafenib in hepatocellular carcinoma patients.

Abstract 4680: Biomarkers of adherence and efficacy: modulation of biomarkers of DNA damage in a Phase 1b trial of post-surgical oral cancer patients on a long-term food-based prevention study with black raspberries.

Abstract 4671: Radioguided detection of lymph node metastasis in non-small cell lung cancer.

Abstract 4662: Epigenetic conversion on p53 pathway in human cancer: The clinical potential of p53 mutation status as a predictive biomarker for drug sensitivity by epigenetic treatment.

Abstract 4681: Characterization of pulmonary hypertension in lung cancer.

Abstract 4661: Clinical study on Compound Zhe Bei Granules (CZBG) combined with chemotherapy to improve the clinical efficacy of refractory acute leukemia.

Abstract 4673: A randomized, double-blind, multicenter trial evaluating the chronotherapeutic role of concomitant melatonin in the treatment of stage IIIB and IV non-small cell lung carcinoma.

Abstract 4682: Phase II study of first line chemotherapy with tegafur/uracil and oral leucovorin in elderly patients with advanced or metastatic colorectal cancer.

Abstract 4675: Effect and safety of FOLFOXIRI+B-mab as preoperative chemotherapy for multiple liver metastases of colorectal cancer.

Abstract 4670: Delayed urticarial reactions in the phase II trial of HER2/neu peptide vaccines + GM-CSF vs. GM-CSF alone in high risk breast cancer patients.

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only